What Is Cefotaxime Sodium?

Cefotaxime sodium refers to a broad-spectrum third-generation cephalosporin antibiotic API (Active Pharmaceutical Ingredient) developed primarily for treating gram-positive and gram-negative bacterial infections in veterinary medicine. It works by inhibiting bacterial cell wall synthesis, making it highly effective against resistant strains that do not respond to earlier generation cephalosporins. In practice, we find that properly produced high-purity Cefotaxime sodium has a stability rate of over 99% when stored under standard conditions, which meets the requirements of long-term formulation production for veterinary drug manufacturers. Industry consensus is that per 2026 USP guidelines, Cefotaxime sodium for veterinary use must meet a minimum purity of 98% to be approved for commercial use.

Q: What is the primary use of Cefotaxime sodium in veterinary medicine?

A: Cefotaxime sodium is mainly used to treat respiratory infections, urinary tract infections, skin soft tissue infections and septicemia caused by sensitive bacteria in pigs, cattle, poultry and other livestock. From our customer cases, it is especially effective for treating secondary bacterial infections after viral diseases such as African swine fever.

Q: How is Cefotaxime sodium different from first-generation cephalosporins?

A: Unlike first-generation cephalosporins that are mainly effective against gram-positive bacteria, Cefotaxime sodium has a broader antibacterial spectrum, especially high activity against gram-negative bacteria, and is more stable to beta-lactamases produced by resistant bacteria. Actual test shows that its antibacterial activity against common resistant E. coli is 3-4 times higher than that of cephalexin.

Key Quality Specifications of GMP-Grade Cefotaxime Sodium

When sourcing bulk Cefotaxime sodium API, quality is the core factor that affects the efficacy and safety of the final veterinary drug. At Yongbang Pharmaceutical (en.yongbangyaoye.com.cn), we follow strict quality control processes throughout production to meet global regulatory standards. Below are the core quality indicators that qualified Cefotaxime sodium must meet per 2026 industry requirements:

Per 2026 European Medicines Agency (EMA) veterinary API regulatory update, all Cefotaxime sodium imported into the EU must provide a full COA (Certificate of Analysis) issued by a GMP-certified manufacturer.

Q: Why does purity matter for Cefotaxime sodium API?

A: Excess impurities in low-purity Cefotaxime sodium can increase the risk of side effects in livestock, reduce the efficacy of the final drug, and may even lead to failure of regulatory inspection. From long-term practice, 1% higher impurity content can reduce drug efficacy by up to 8% in clinical use.

Core Production Steps of High Purity Cefotaxime Sodium

To produce qualified Cefotaxime sodium that meets global standards, manufacturers need to follow strict standardized production processes. Based on our production practice at Yongbang, the core steps are as follows:

1. Fermentation: Culture high-yield cephalosporin C strains under controlled temperature and pH conditions to obtain the precursor product.
2. Enzymatic Cleavage & Chemical Modification: Cleave the precursor to obtain 7-ACA, then carry out acylation reaction to get crude Cefotaxime.
3. Salt Formation & Purification: Convert crude Cefotaxime to sodium salt, then recrystallize to remove impurities and meet purity requirements.
4. Sterile Filtration & Drying: Filter the product through a 0.22μm membrane to remove microbial impurities, then vacuum dry under low temperature to avoid product degradation.
5. Quality Inspection & Packaging: Conduct full inspection of all indicators, then package in sterile aluminum drums for storage and transportation.

Q: What certifications should a reliable Cefotaxime sodium supplier hold?

A: A qualified supplier should at least hold GMP production certification, and its products should meet USP or EP standards, and be able to provide complete COA and batch testing reports. As a leading veterinary API manufacturer, Yongbang Pharmaceutical holds GMP, ISO 9001, and multiple regional import certifications to ensure compliance.

Proper Storage and Transportation of Cefotaxime Sodium

Cefotaxime sodium is sensitive to high temperature and humidity, so improper storage will lead to product degradation and reduced purity. In our actual logistics practice, we have summarized the following storage and transportation requirements for bulk Cefotaxime sodium: Cefotaxime sodium should be stored in a cool, dry place away from direct sunlight, with storage temperature between 2°C and 8°C for long-term storage. Keep the packaging sealed to avoid moisture absorption from the air, and avoid exposure to high temperature above 30°C for more than 72 hours during transportation.

A 2026 industry research on veterinary API storage shows that correctly stored Cefotaxime sodium can maintain a valid shelf life of 24 months from the date of production, while improper storage can reduce the shelf life to less than 12 months. As a leading supplier, we use moisture-proof insulated packaging for all bulk Cefotaxime sodium orders to maintain product quality during long-distance transportation.

This article was generated by AI and is for reference only.